The Market Doesn't Like What It Sees From Vitura Health Limited's (ASX:VIT) Earnings Yet As Shares Tumble 43%
Apr 25
Australian (ASX) Pharma Industry Analysis
UpdatedApr 26, 2024
DataAggregated Company Financials
Companies30
- 7D-3.3%
- 3M-6.3%
- 1Y29.3%
- YTD-9.4%
Over the last 7 days, the Pharma industry has dropped 2.6%, driven by Neuren Pharmaceuticals declining 4.2%. On the other hand Recce Pharmaceuticals is actually up 33%. In the past year, the industry has gained 29%. Earnings are forecast to grow by 28% annually.
Industry Valuation and Performance
Has the Australian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Apr 2024 | AU$5.5b | AU$1.2b | -AU$374,923,684.00 | 13.2x | -14.6x | 4.5x |
| Sun, 24 Mar 2024 | AU$5.6b | AU$1.2b | -AU$374,923,684.00 | 15.3x | -15x | 4.6x |
| Tue, 20 Feb 2024 | AU$5.4b | AU$892.3m | -AU$534,729,129.00 | 20.6x | -10.2x | 6.1x |
| Thu, 18 Jan 2024 | AU$5.6b | AU$896.3m | -AU$589,604,392.00 | 21x | -9.5x | 6.3x |
| Sat, 16 Dec 2023 | AU$4.6b | AU$896.3m | -AU$589,604,392.00 | 17.8x | -7.8x | 5.1x |
| Mon, 13 Nov 2023 | AU$4.0b | AU$893.0m | -AU$595,020,018.00 | 18.1x | -6.7x | 4.5x |
| Wed, 11 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 19.3x | -5.9x | 3.9x |
| Fri, 08 Sep 2023 | AU$3.6b | AU$900.3m | -AU$587,952,018.00 | 19.5x | -6.2x | 4x |
| Sun, 06 Aug 2023 | AU$4.1b | AU$999.0m | -AU$624,794,303.00 | 21.1x | -6.5x | 4.1x |
| Tue, 04 Jul 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 24.3x | -6.3x | 4x |
| Thu, 01 Jun 2023 | AU$4.1b | AU$993.2m | -AU$640,306,659.00 | 18.8x | -6.3x | 4.1x |
| Sat, 29 Apr 2023 | AU$4.3b | AU$993.2m | -AU$641,969,868.00 | 20.5x | -6.7x | 4.3x |
| Mon, 27 Mar 2023 | AU$4.0b | AU$995.9m | -AU$648,651,745.00 | 18.2x | -6.2x | 4.1x |
| Wed, 22 Feb 2023 | AU$3.6b | AU$981.5m | -AU$594,318,566.00 | 16.6x | -6x | 3.6x |
| Fri, 20 Jan 2023 | AU$3.7b | AU$948.3m | -AU$544,428,006.00 | 13x | -6.9x | 3.9x |
| Sun, 18 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,006.00 | 13.3x | -7.1x | 4.1x |
| Tue, 15 Nov 2022 | AU$4.3b | AU$948.3m | -AU$544,428,005.00 | 13.2x | -7.9x | 4.5x |
| Thu, 13 Oct 2022 | AU$4.2b | AU$882.1m | -AU$556,645,005.00 | 12.2x | -7.5x | 4.7x |
| Sat, 10 Sep 2022 | AU$4.2b | AU$943.4m | -AU$537,548,829.00 | 12.7x | -7.8x | 4.4x |
| Mon, 08 Aug 2022 | AU$3.9b | AU$819.9m | -AU$339,669,589.00 | 15.6x | -11.6x | 4.8x |
| Wed, 06 Jul 2022 | AU$3.4b | AU$818.2m | -AU$353,932,589.00 | 13.2x | -9.5x | 4.1x |
| Fri, 03 Jun 2022 | AU$3.9b | AU$818.2m | -AU$353,932,589.00 | 14.8x | -11.1x | 4.8x |
| Sun, 01 May 2022 | AU$4.1b | AU$800.9m | -AU$348,637,558.00 | 15.7x | -11.7x | 5.1x |
| Tue, 29 Mar 2022 | AU$4.2b | AU$799.2m | -AU$341,805,125.00 | 18.1x | -12.4x | 5.3x |
| Thu, 24 Feb 2022 | AU$4.4b | AU$743.6m | -AU$460,156,833.00 | 19.9x | -9.6x | 5.9x |
| Sat, 22 Jan 2022 | AU$4.8b | AU$758.4m | -AU$450,516,414.00 | 20.6x | -10.6x | 6.3x |
| Mon, 20 Dec 2021 | AU$4.8b | AU$758.4m | -AU$450,516,414.00 | 23.7x | -10.5x | 6.3x |
| Wed, 17 Nov 2021 | AU$4.9b | AU$758.4m | -AU$447,307,205.00 | 24.1x | -11x | 6.5x |
| Fri, 15 Oct 2021 | AU$4.7b | AU$753.7m | -AU$446,965,453.00 | 23.5x | -10.6x | 6.3x |
| Sun, 12 Sep 2021 | AU$4.8b | AU$753.9m | -AU$445,060,581.00 | 21.9x | -10.7x | 6.3x |
| Tue, 10 Aug 2021 | AU$4.1b | AU$752.8m | -AU$442,004,016.00 | 21.3x | -9.3x | 5.4x |
| Mon, 03 May 2021 | AU$4.8b | AU$758.7m | -AU$449,177,839.00 | 12.3x | -10.6x | 6.3x |
Price to Earnings Ratio
-10.6x
Current Industry PE
- Investors are pessimistic on the Australian Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.0x is higher than the industry's current PS ratio of 4.5x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Revenues for these companies have grown 17% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Australian Healthcare industry?
| AU Market | 0.42% | |
| Healthcare | 2.56% | |
| Pharma | -3.26% | |
| Pharma | -3.26% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| RCE Recce Pharmaceuticals | AU$0.69 | 33.0% +AU$34.7m | 7.9% | PS20.7x | |
| MYX Mayne Pharma Group | AU$7.10 | 5.2% +AU$28.4m | 74.4% | PS1.8x | |
| AGN Argenica Therapeutics | AU$0.56 | -3.4% AU$10.9m | 27.3% | PS25.2x | |
| IVX Invion | AU$0.006 | 20.0% +AU$6.4m | -14.3% | PS8.8x | |
| SPL Starpharma Holdings | AU$0.14 | 8.0% +AU$4.1m | -71.9% | PS5.3x |
